Will you have Hearing loss with Malignant melanoma - from FDA reports

Summary

Hearing loss is found among people with Malignant melanoma, especially for people who are female, 60+ old, take medication Tafinlar and have Lung neoplasm malignant. This study is created by eHealthMe based on reports of 31 people who have Malignant melanoma from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on Hearing loss and Malignant melanoma, and their synonyms.

What is Malignant melanoma?

Malignant melanoma (skin cancer rises from melancytes) (latest reports from 29,740 Malignant melanoma patients)

What is Hearing loss?

Hearing loss has been reported by people with rheumatoid arthritis, high blood pressure, osteoporosis, multiple sclerosis, high blood cholesterol (latest reports from 16,616 Hearing loss patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 25, 2019

31 people who have Malignant Melanoma and Hearing Loss are studied.


Number of reports submitted per year:

Would you have Hearing loss when you have Malignant melanoma?

Gender of people who have Malignant Melanoma and experience Hearing Loss *:

  • female: 58.06 %
  • male: 41.94 %

Age of people who have Malignant Melanoma and experience Hearing Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 16 %
  • 40-49: 4 %
  • 50-59: 36 %
  • 60+: 44 %

Top co-existing conditions for these people *:

  1. Preventive Health Care: 2 people, 6.45%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 6.45%
  3. Pain: 1 person, 3.23%
  4. Nausea (feeling of having an urge to vomit): 1 person, 3.23%
  5. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 3.23%
  6. Metastases To Lung (cancer spreads to lung): 1 person, 3.23%
  7. Lipids Abnormal: 1 person, 3.23%
  8. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 3.23%
  9. High Blood Pressure: 1 person, 3.23%
  10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 3.23%

Most common drugs for these people *:

  1. Yervoy: 4 people, 12.90%
  2. Tafinlar: 4 people, 12.90%
  3. Keytruda: 3 people, 9.68%
  4. Mekinist: 3 people, 9.68%
  5. Zelboraf: 2 people, 6.45%
  6. Opdivo: 2 people, 6.45%
  7. Lyrica: 2 people, 6.45%
  8. Prochlorperazine Maleate: 1 person, 3.23%
  9. Tribenzor: 1 person, 3.23%
  10. Amlodipine Besylate: 1 person, 3.23%

Top symptoms for these people *:

  1. Rashes (redness): 9 people, 29.03%
  2. Diarrhea: 8 people, 25.81%
  3. Malignant Neoplasm Progression (cancer tumour came back): 8 people, 25.81%
  4. Dizziness: 6 people, 19.35%
  5. Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 16.13%
  6. Fever: 5 people, 16.13%
  7. Tumor Haemorrhage: 5 people, 16.13%
  8. Back Pain: 5 people, 16.13%
  9. Weakness: 4 people, 12.90%
  10. Diplopia (double vision): 4 people, 12.90%

* Approximation only. Some reports may have incomplete information.



Do you have Hearing loss with Malignant melanoma?

You are not alone:




Related publications that referenced our studies

Related studies

Drugs that are associated with Hearing loss
Hearing loss (2,100 drugs)
Other conditions that could cause Hearing loss
Hearing loss (1,792 conditions)
Browse all symptoms of Malignant melanoma
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you have Hearing loss and Malignant melanoma



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.